title: WHO survey finds half of countries do not have clinical guidelines for treating hepatitis.
authors.forename: Anne
authors.initials: A
authors.lastname: Gulland
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D018954:Drugs, Essential; D014943:Global Health; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006292:Health Priorities; D006509:Hepatitis B / Q000188:drug therapy* / Q000453:epidemiology; D006526:Hepatitis C / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D063065:Organophosphonates / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D000068698:Tenofovir; D014944:World Health Organization
chemical_list: D000998:Antiviral Agents; D018954:Drugs, Essential; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D063065:Organophosphonates; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C413685:entecavir; D006147:Guanine; D000068698:Tenofovir; C417083:peginterferon alfa-2b; D000225:Adenine; C100416:peginterferon alfa-2a